Tech Company Financing Transactions
Pheon Therapeutics Funding Round
TCGX, Atlas Venture and Brandon Capital Partners invested in a $120 million Series B funding round for Pheon Therapeutics. The round was announced on 5/21/2024.
Transaction Overview
Company Name
Announced On
5/21/2024
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to further advance its differentiated ADC pipeline through clinical proof of concept, and expand its suite of in-house technology platforms to generate optimized ADC constructs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
903 Sneath Lane 123
San Bruno, CA 94066
USA
San Bruno, CA 94066
USA
Phone
Undisclosed
Website
Email Address
Overview
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bertrand Damour
Chief Scientific Officer
Leigh Zawel
Vice President
Chi-Ting Huang
Vice President
Paul Jackson
Browse more venture capital transactions:
Prev: 5/21/2024: Tuesday Health venture capital transaction
Next: 5/21/2024: SamaCare venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs